The Enterprise Value as of December 2025 (TTM) for Parmax Pharma Limited (PARMAX.BO) is 206.14M

According to Parmax Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 206.14M. This represents a change of 73.10% compared to the average of 119.09M of the last 4 quarters.

Parmax Pharma Limited (PARMAX.BO) Historical Enterprise Value (quarterly & annually)

How has PARMAX.BO Enterprise Value performed in the past?

The mean historical Enterprise Value of Parmax Pharma Limited over the last ten years is 116.83M. The current 206.14M Enterprise Value has changed 17.55% with respect to the historical average. Over the past ten years (40 quarters), PARMAX.BO's Enterprise Value was at its highest in in the March 2025 quarter at 245.20M. The Enterprise Value was at its lowest in in the September 2015 quarter at 0.

Parmax Pharma Limited (PARMAX.BO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Parmax Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Parmax Pharma Limited (PARMAX.BO) Average Enterprise Value

How has PARMAX.BO Enterprise Value performed in the past?

The current Enterprise Value of Parmax Pharma Limited (PARMAX.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Parmax Pharma Limited (PARMAX.BO) Enterprise Value vs. Peers

How is PARMAX.BO’s Enterprise Value compared to its peers?

Parmax Pharma Limited’s Enterprise Value is greater than Evoq Remedies Limited (67.89M), less than Cian Healthcare Limited (361.10M), greater than Beryl Drugs Limited (110.26M), greater than Decipher Labs Ltd. (100.39M), greater than Colinz Laboratories Limited (104.23M), greater than Emmessar Biotech & Nutrition Limited (145.89M), greater than Gian Life Care Limited (107.66M), greater than Shamrock Industrial Co. Ltd. (100.18M), greater than Vivanza Biosciences Limited (88.00M), greater than Span Divergent Limited (174.34M),

Build a custom stock screener for Parmax Pharma Limited (PARMAX.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Parmax Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Parmax Pharma Limited (PARMAX.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Parmax Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.